These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 826828)

  • 1. Non-adaptive rejection of small tumour inocula as a model of immune surveillance.
    Greenberg AH; Greene M
    Nature; 1976 Nov; 264(5584):356-9. PubMed ID: 826828
    [No Abstract]   [Full Text] [Related]  

  • 2. Low numbers of tumor cells suppress the host immune system.
    Kölsch E; Mengersen R
    Adv Exp Med Biol; 1976; 66():431-6. PubMed ID: 817574
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.
    Chow DA; Greene MI; Greenberg AH
    Int J Cancer; 1979 Jun; 23(6):788-97. PubMed ID: 223992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 6. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of effector T lymphocytes against a tumor allograft by T lymphocytes sensitized in vitro.
    Treves AJ; Cohen IR
    J Natl Cancer Inst; 1973 Dec; 51(6):1919-25. PubMed ID: 4543604
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 9. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host.
    Mengersen R; Schick R; Kölsch E
    Eur J Immunol; 1975 Aug; 5(8):532-7. PubMed ID: 61875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytotoxic mechanisms induced by minor histocompatibility antigens in the mouse.
    Jones B
    Cell Immunol; 1978 Jun; 38(1):157-67. PubMed ID: 96941
    [No Abstract]   [Full Text] [Related]  

  • 12. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamics of immunity in syngeneic lymphoma-bearing mice.
    Jurin M; Plavsić B
    Eur J Cancer (1965); 1978 Jun; 14(6):653-9. PubMed ID: 350589
    [No Abstract]   [Full Text] [Related]  

  • 15. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B; Jones TC; Roitt IM
    Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 17. The differentiation pathway of T lymphocytes. Evidence for two differentiated cell types.
    Matter A
    J Exp Med; 1974 Aug; 140(2):566-77. PubMed ID: 4152545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape of small numbers of allogeneic lymphoma cells from immune surveillance.
    Bonmassar E; Menconi E; Goldin A; Cudkowicz G
    J Natl Cancer Inst; 1974 Aug; 53(2):475-9. PubMed ID: 4843273
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental models with possible implications for the role of HLA in malignancy.
    Williams RM
    Prog Clin Biol Res; 1977; 16():21-8. PubMed ID: 410036
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic differences in F1 hybrid resistance against tumours of the same parental strain. I. Tumours of C57Bl/6 origin.
    Klein GO; Klein G
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):731-42. PubMed ID: 6800800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.